Affiliation:
1. Pediatric Neurology Unit, Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College, Pune, Maharashtra, India
Abstract
AbstractResurgence of subacute sclerosing panencephalitis (SSPE)—case series and global epidemiological trends. We noted a recent increase in cases of SSPE admitted in our institute, even though they had received measles vaccination. We did a detailed study of our cases and compared with global epidemiological trends of SSPE in preimmunization and era of developed immunity. Out of total 23 cases of SSPE, 12 presented in the year 2017 alone, reflecting a steep rise in incidence. Sixteen patients had received measles vaccine and never had prior measles infection. Mean age of onset was 8.2 years and average time of progression to advanced stage of disease was 65 days. Global data showed similar trends, that is, earlier age of onset with a faster rate of progression in the postvaccination era as compared with prevaccine era. Possible mechanisms to account for this trend include an early wild measles infection in the critical age of 6 to 9 months, before vaccination. There is a changing epidemiological trend of SSPE in terms of lower age of onset and faster rate of progression, also reflected in global data. There is a need for multicenter studies to verify the findings and explore possible measures like lowering the age of measles vaccination to halt this alarming trend.
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference48 articles.
1. Subacute sclerosing panencephalitis;R K Garg;Indian Pediatr,1998
2. Measles viral load may reflect SSPE disease progression;M Kühne Simmonds;Virol J,2006
3. Subacute sclerosing panencephalitis revisited. Internat;V Sardana;J. of Basic and Applied Medical Sciences,2013
4. Subacute sclerosing pan encephalitis despite adequate vaccination;B Malik;Australas Med J,2012
5. High incidence of subacute sclerosing panencephalitis in south India;V Saha;Epidemiol Infect,1990